# RETHYMIC

NDC: 72359-001
Generic name: allogenic thymocyte-depleted thymus tissue-agdc
Labeler / Manufacturer: Sumitomo Pharma America, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: IMPLANT
Routes: INTRAMUSCULAR
Marketing started: 20211008

FDA application: BLA125685

## Active ingredients

- ALLOGENEIC THYMOCYTE-DEPLETED THYMUS TISSUE-AGDC: 22000 mm/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72359-001"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72359-001
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e0022c28-8cda-4f1e-bcf1-1f440d37ec4a